B
uruli ulcer (BU), the third most common mycobacterial disease after tuberculosis and leprosy, is a major health problem in several West and Central African countries (1) . Although endemic in Central America and subtropical climates of Southeast Asia and Australia, countries in Africa in the past decade have recorded increased incidence rates in some communities exceeding that of tuberculosis (2).
Mode(s) of transmission, natural reservoir(s) and other key aspects of the epidemiology of BU are not fully understood, a situation partly complicated by an apparent lack of genetic diversity of Mycobacterium ulcerans, as shown by several independent genetic markers (3-6). Conventional and molecular data suggest that M. ulcerans is an environmental pathogen because of the selective association of BU-endemic foci with wetlands and overflowed river banks and the detection of M. ulcerans-specific sequences in water, mud, aquatic insects, and plants (7) (8) (9) . Specific reservoirs of the etiologic agent cannot be definitively assigned; however, we have cultivated M. ulcerans from a single aquatic insect from Benin (10) .
Extensive molecular typing of M. ulcerans isolates recovered from patients in many endemic foci has been undertaken to further the understanding of the epidemiology of BU. A set of robust genotyping methods has already been applied to M. ulcerans: IS2404 restriction fragment length polymorphism (11) , amplified fragment length polymorphism analysis (AFLP) (12) , multilocus sequence typing (13) , variable-number tandem repeat (VNTR) (3), mycobacterial interspersed repetitive unit (MIRU)-VNTR (6), IS2426 polymerase chain reaction (PCR) (5), and IS2404-Mtb2 PCR (4). All methods, except AFLP, resulted in geographically related genotypes for China, Japan, Mexico, Suriname, French Guiana, Malaysia, Papua New Guinea II and Papua New Guinea III, Australia Victoria, Australia Queensland, and Africa. Current typing methods have established a striking geographic and temporal homogeneity in African isolates from Angola, Benin, Democratic Republic of Congo (DRC), Ghana, Côte d'Ivoire, and Togo (3-6). Even M. ulcerans cultured from the insect collected in Benin showed an identical African genotype (6) . Recently, however, Hilty et al., using a VNTR typing method and sequence analysis, described 3 genotypes in Ghana (14) . The development of more discriminating typing methods may unravel the source and mode of transmission of M. ulcerans and other epidemiologic aspects of BU.
Improved understanding of the molecular biology of M. ulcerans will likely help elucidate observed differences in clinical manifestations. Reported disease recurrence rates vary from 6% to >20% (15) . To what degree this recurrence is attributable to exogenous reinfection or dissemination of the pathogen from previous lesions is unknown. The relative contribution of variations in pathogen and host factors to progression and severity of disease likewise remains obscure.
We report the first evidence of genetic diversity in M. ulcerans samples from 3 African countries: DRC, Sudan, and Uganda. Previously, we identified tandem repeat loci, MIRUs (6), and VNTRs (3) in the genome of M. ulcerans. A selection of these MIRUs and VNTRs were used in this study to analyze M. ulcerans extracts from tissue specimens from Benin, Togo, Gabon, Uganda, and Sudan, and from previous isolates from patients from Cameroon, DRC, Uganda, and Congo-Brazzaville (Table 1) . Results were compared with those of a geographically diverse collection (n = 39) that were typed in our previous study (6) .
The Study
To investigate the MIRU polymorphism, whole genomic DNA was prepared from bacterial cultures or clinical specimens. The specimens were tissue fragments from patients with nonulcerated (plaques and edematous forms) or ulcerated forms. DNA extraction from pure cultures was performed by heating the colonies in Tris-EDTA at 95°C for 10 minutes. Clinical specimens from laboratory-confirmed cases of BU were decontaminated by using the reversed Petroff method, and mycobacterial DNA was extracted from the decontaminated solution as previously described (6) . Smears of the suspensions were stained by the Ziehl-Neelsen method.
PCR was run as previously described (6) . The Agilent 2100 Bioanalyzer system (Agilent Technologies, Waldbronn, Germany) was used to separate 1 µL of PCR product electrophoretically.
Comparison of MIRU-VNTR copy numbers using 4 loci showed 11 different profiles. M. ulcerans isolates from DRC and Uganda and tissue extracts from patients from Sudan (Nzara) and Uganda (Nakasongola) showed distinct profiles (Central Africa: 1222 and East Africa: 4111), different from the originally homogeneous African genotype (Atlantic Africa: 3113; Table 1 ). In DRC, 3 different genotypes exist, corresponding to 3 different provinces: BasCongo, Maniema (Kasongo), and Orientale (Bunia). The isolate from Orientale was from near the Ugandan border (Lake Albert). Isolates from Gabon, Congo-Brazzaville, and Cameroon had the typical African genotype, now designated the Atlantic African genotype. Identical MIRU-VNTR profiles were observed by using DNA extracted from tissues or cultures from patients residing in the same area. The specificity of the MIRU-VNTR method was tested on 14 different Mycobacterium spp. Only M. marinum, M. shottsii, and M. liflandii tested positive, but they were distinguished from M. ulcerans by exhibiting different profiles (data not shown). Sequencing of the concerned loci showed the conserved MIRU sequence at locus 1 and 9 in M. ulcerans. Locus 6 (3) and locus 33 contain respectively a 56-bp and a 58-bp tandem repeat (Table 2) .
Conclusions
Although M. ulcerans isolates from Africa are relatively homogeneous, this study demonstrates more heterogeneity between strains than previously reported. All isolates from West Africa (Côte d'Ivoire, Ghana, Togo, Benin) and Central Africa (Cameroon; Gabon; CongoBrazzaville; DRC Bas-Congo; Angola) have the identical MIRU-VNTR profile, and all originate from regions (i.e., Bas-Congo) or countries that border the Atlantic Ocean. The isolates that come from regions or countries in the Nile River basin (i.e., Orientale in DRC, Sudan, and Uganda) or the Congo River basin (i.e., Maniema) have distinct profiles.
These results demonstrate for the first time heterogeneity among M. ulcerans from different African countries. The 3 African profiles are the Atlantic African profile, the Central African Congo River basin profile, and the East African Nile River basin profile. This is also the first detection of MIRUs and VNTRs in clinical specimens, even in smear-negative specimens.
These data show that MIRUs and VNTRs are helpful tools in genotyping M. ulcerans. Further detailed differentiation of this etiologic agent will lead to an understanding of the epidemiology of BU. As in tuberculosis, better discriminatory typing methods help assess the efficacy of antimycobacterial treatment of BU patients by differentiating reactivation from reinfection. Although M. ulcerans appears to be quite monomorphic, full sequencing of this organism will permit detection of genes specific for M. ulcerans, and more discriminatory VNTR should become available.
